ReviewCNS oncology2015
Depression screening in patients with brain tumors: a review.
Review in CNS oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- Employment and Work Ability of Persons With Brain Tumors: A Systematic Review.Frontiers in human neuroscience · 2020Pooled it
- Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis.BMC cancer · 2018Pooled it
- Neuropsychiatric symptoms and clinical characteristics of survivors with colloid cysts.Orphanet journal of rare diseases · 2025Article
- Symptom management in isocitrate dehydrogenase mutant glioma.Neuro-oncology practice · 2025Review
- Home Care for the Elderly: An Integrated Approach to Perception, Quality of Life, and Cognition.International journal of environmental research and public health · 2024Article
- Antidepressants and survival in glioma-A registry-based retrospective cohort study.Neuro-oncology practice · 2024Article
- [Rational treatment of depressive syndromes in brain tumor patients].Der Nervenarzt · 2024Review
- The emotional journey of neuro-oncology: Primary brain tumor patients share their experience during this life-threatening disease.Neuro-oncology practice · 2023Article
- Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendations.Neuro-oncology practice · 2022Review
- Article
- Associations ofInternational journal of molecular sciences · 2022Article
- Classical and disease-specific quality indicators in glioma surgery-Development of a quality checklist to improve treatment quality in glioma patients.Neuro-oncology practice · 2022Article
- Blood Inflammatory Cytokines as Predictors of Depression in Patients With Glioma.Frontiers in psychiatry · 2022Article
- Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.Irish journal of medical science · 2021Article
- Health-related quality of life in patients with primary brain tumors during and three months after treatment with proton beam therapy.Technical innovations & patient support in radiation oncology · 2021Article
- Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Article
- Cognitive functioning following brain irradiation as part of cancer treatment: Characterizing better cognitive performance.Psycho-oncology · 2019Article
- Association of miR-34a Expression with Quality of Life of Glioblastoma Patients: A Prospective Study.Cancers · 2019Article
- Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma.International journal of molecular sciences · 2018Article
- Association between depression and brain tumor: a systematic review and meta-analysis.Oncotarget · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumor (BT) is often a devastating disease associated with poor prognosis. Depression is a common complication in BT patients that often remains under-recognized and untreated. Implementation of reliable depression screening algorithms in routine neuro-oncology setting could potentially improve recognition of depression. The Hospital Anxiety and Depression scale-Depression subscale and Patient Health Questionnaire-9 demonstrated adequate psychometric properties for depressive disorder screening in glioma patients. Patients screened positive for depression should be referred for detailed psychiatric assessment prior to initiating anti-depressive treatment. Further methodologically rigorous studies investigating psychometric properties of single-item and multiple-item depression scales are urgently warranted. Studies evaluating anti-depressive treatments' efficacy and clinical value of depression biomarkers are important avenues for future research endeavors in BT patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.